/Paliperidone Double-blind, Placebo- and Active-Controlled, Study

Description

ORIGINAL RESEARCH

Efficacy and Safety of Paliperidone Extended Release 1.5 mg/day—A Double-blind, Placebo- and Active-Controlled, Study in the Treatment of Patients with Schizophrenia

Danielle Coppola, Rama Melkote, Caroline Lannie, Jaskaran Singh, Isaac Nuamah, Srihari Gopal, David Hough, Joseph Palumbo

PB-44-2-2011-Coppola